ELABPMGC HOLDINGS INC.
Is PMGC Holdings struggling financially?
Yes, by its own account. PMGC Holdings told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.
Going concern disclosed May 2026
30/100
Fragile
- Sector
- Biotech/Pharma
- Market cap
- $53.9M
- Source filing
- 10-Q 15 May 2026
- Balance sheet
- 30 Jun 2026
Cash runway
29+ mo
Runs out some time after Nov 2028, raising nothing.
Out of cashTwo years or more
The runway math
Cash and short-term investments
$18.1M
÷
Cash burned over the last 12 months
$6.4M
What PMGC Holdings told the SEC
…of $ 4,967,259 and $ 1,608,455 , respectively and used $ 2,979,595 and $ 1,347,416 , respectively of cash flows for operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of…
PMGC HOLDINGS INC., Form 10-Q, filed 15 May 2026.
Read the filing on SEC.govWhat this means
- Not a bankruptcy filing, and not a prediction.
- It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
- The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.
What else the numbers show
- 198.2% share-count increase The company issued stock. Each share now owns 66.5% less of the business than a year ago, before any change in the price.
- Cash burn is narrowing It is spending 33% less cash per year than it was, so the runway above is lengthening rather than shortening.
Other Biotech/Pharma companies that filed the doubt
- EQ Equillium $146.5M
- IVVD Invivyd $293.7M
- QNCX Quince Therapeutics $34.5M
- DERM Journey Medical $218.7M
- AMS American Shared Hospital Services $10.0M
- IBIO iBio $71.0M